BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 27977138)

  • 21. Proteomic approaches to studying protein tyrosine phosphatases.
    Liang F; Kumar S; Zhang ZY
    Mol Biosyst; 2007 May; 3(5):308-16. PubMed ID: 17460790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation.
    Miao J; Zhang ZY
    ChemMedChem; 2024 Apr; 19(7):e202300669. PubMed ID: 38233347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides.
    Burke TR; Ye B; Akamatsu M; Ford H; Yan X; Kole HK; Wolf G; Shoelson SE; Roller PP
    J Med Chem; 1996 Mar; 39(5):1021-7. PubMed ID: 8676336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational design of selective organoruthenium inhibitors of protein tyrosine phosphatase 1B.
    Ong JX; Yap CW; Ang WH
    Inorg Chem; 2012 Nov; 51(22):12483-92. PubMed ID: 23121648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptidomimetic competitive inhibitors of protein tyrosine phosphatases.
    Shen K; Qi L; Stiff L
    Curr Pharm Des; 2010; 16(28):3101-17. PubMed ID: 20687872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A New Paradigm for KIM-PTP Drug Discovery: Identification of Allosteric Sites with Potential for Selective Inhibition Using Virtual Screening and LEI Analysis.
    Adams J; Thornton BP; Tabernero L
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of protein tyrosine phosphatases: next-generation drugs?
    Bialy L; Waldmann H
    Angew Chem Int Ed Engl; 2005 Jun; 44(25):3814-39. PubMed ID: 15900534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based design and discovery of novel inhibitors of protein tyrosine phosphatases.
    Huang P; Ramphal J; Wei J; Liang C; Jallal B; McMahon G; Tang C
    Bioorg Med Chem; 2003 Apr; 11(8):1835-49. PubMed ID: 12659770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Druggability analysis and classification of protein tyrosine phosphatase active sites.
    Ghattas MA; Raslan N; Sadeq A; Al Sorkhy M; Atatreh N
    Drug Des Devel Ther; 2016; 10():3197-3209. PubMed ID: 27757011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting protein tyrosine phosphatases for anticancer drug discovery.
    Scott LM; Lawrence HR; Sebti SM; Lawrence NJ; Wu J
    Curr Pharm Des; 2010 Jun; 16(16):1843-62. PubMed ID: 20337577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tapping the therapeutic potential of protein tyrosine phosphatase 4A with small molecule inhibitors.
    Tasker NR; Rastelli EJ; Burnett JC; Sharlow ER; Lazo JS; Wipf P
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2008-2015. PubMed ID: 31307888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteinaceous Regulators and Inhibitors of Protein Tyrosine Phosphatases.
    Hendriks W; Bourgonje A; Leenders W; Pulido R
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29439552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A combinatorial strategy for the acquisition of potent and specific protein tyrosine phosphatase inhibitors.
    Zhang S; Chen L; Lawrence DS; Zhang ZY
    Methods Mol Biol; 2012; 928():53-65. PubMed ID: 22956133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein tyrosine phosphatase inhibitors: a patent review (2002 - 2011).
    Sobhia ME; Paul S; Shinde R; Potluri M; Gundam V; Kaur A; Haokip T
    Expert Opin Ther Pat; 2012 Feb; 22(2):125-53. PubMed ID: 22332719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic substrate enhancement for the identification of specific, second-site-binding fragments targeting a set of protein tyrosine phosphatases.
    Schmidt MF; Groves MR; Rademann J
    Chembiochem; 2011 Nov; 12(17):2640-6. PubMed ID: 22052725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a benzo imidazole thiazole derivative as the specific irreversible inhibitor of protein tyrosine phosphatase.
    Ge L; Li KS; Li MM; Xiao P; Hou XB; Chen X; Liu HD; Lin A; Yu X; Ren GJ; Fang H; Sun JP
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4795-4798. PubMed ID: 27554446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B.
    Lee S; Wang Q
    Med Res Rev; 2007 Jul; 27(4):553-73. PubMed ID: 17039461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating virtual and biochemical screening for protein tyrosine phosphatase inhibitor discovery.
    Martin KR; Narang P; Medina-Franco JL; Meurice N; MacKeigan JP
    Methods; 2014 Jan; 65(2):219-28. PubMed ID: 23969317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview of the protein tyrosine phosphatase superfamily.
    Wang WQ; Sun JP; Zhang ZY
    Curr Top Med Chem; 2003; 3(7):739-48. PubMed ID: 12678841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small molecule tools for functional interrogation of protein tyrosine phosphatases.
    He R; Zeng LF; He Y; Zhang S; Zhang ZY
    FEBS J; 2013 Jan; 280(2):731-50. PubMed ID: 22816879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.